Market Research Blog – Page 10157 – New Product Development

Portable Oxygen Concentrators Market Expected to Witness a CAGR of 10.1% through 2022-2032

By the end of 2022, the global portable oxygen concentrators market is anticipated to reach US$ 1.9 billion, and it is projected to grow at a CAGR of 10.1% from 2022 to 2032. By 2032, market sales are anticipated to surpass US$ 5.0 Bn.

Portable oxygen concentrators supply oxygen to patients suffering from respiratory diseases such as chronic obstructive pulmonary diseases. The concentrator separates nitrogen and oxygen from air in the environment and then supplies 95% pure oxygen to patients. POCs are easy to carry as they are smaller in size compared to stationary concentrators. Moreover, POCs are of great use to mountaineers and travellers in places where oxygen is inadequate.

According to Future Market Insights, the global portable oxygen concentrators market is likely to witness substantial growth owing to increasing prevalence of chronic obstructive pulmonary diseases, growing consumer awareness for oxygen therapy devices, and a changing consumer lifestyle. Further, adoption of new technologies in medical devices, increasing government expenditure towards healthcare and medical devices development and production, and a rise in investment by companies manufacturing homecare products is likely to boost the growth of the global portable oxygen concentrators market during the forecast period (2016 – 2026).

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1061

However, high product costs and stringent FDA regulations pertaining to medical devices are some of the factors likely to restrain the growth of the global portable oxygen concentrators market during the forecast period.

Segmentation highlights

The global portable oxygen concentrators market has been segmented on the basis of Product into Continuous Flow Portable Oxygen Concentrator and Pulse Flow Portable Oxygen Concentrator; and on the basis of End User into Hospitals, Homecare, Ambulatory Surgical Centres, and Travel Agents.

The Pulse Flow Portable Oxygen Concentrator product segment is projected to be valued at US$ 1890.3 Mn by 2026, registering a CAGR of 9.0% over the forecast period
The Homecare end user segment is projected to be valued at US$ 1820.5 Mn by 2026 and is likely to witness a CAGR of 9.0% over the forecast period

Regional market projections

The global portable oxygen concentrators market is segmented into the seven key regions of North America, Latin America, Western Europe, Eastern Europe, APEJ, MEA, and Japan. Growing geriatric population consequently increasing the requirement for homecare settings particularly in high income countries with increasing number of patients suffering from chronic obstructive pulmonary diseases is expected to result in significant growth of the North America portable oxygen concentrators market.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1061

The North America region is expected to report incremental opportunity of US$ 781.7 Mn between 2016 and 2026. Evolution of health insurance system is expected to contribute largely to the revenue generation potential and attractiveness of the Eastern Europe portable oxygen concentrators market. Rising adoption of portable oxygen concentrators in chronic obstructive pulmonary diseases patients for better care is expected to fuel revenue growth in the Japan portable oxygen concentrators market over the forecast period. High product cost of portable oxygen concentrators is expected to hamper sustainable adoption in the APEJ region. Lack of product awareness is expected to hamper market growth in the APEJ and MEA regions.

Vendor insights

The report profiles some of the top companies operating in the global portable oxygen concentrators market such as Koninklijke Philips N.V., Inogen Inc., Chart Industries Inc., Resmed Inc., Invacare Corporation, Drive DeVilbiss Healthcare, Precision Medical Inc., Besco Medical Co. Ltd., Oxus America, Inc. (Oxus), Foshan Keyhub Electronic Industries Co. Ltd., O2 Concepts LLC, and GCE Group. Key strategies adopted by leading market players in the global portable oxygen concentrators market include product approvals and commercialisation, efficient entry into markets in emerging countries, and adoption of latest innovative technologies in healthcare, thus strengthening regional proficiency and addressing customer needs effectively. New product launches, product innovation, and geographical expansion are anticipated to form the core of these strategies during the forecast period.

Market segmentation

By Product

Continuous Flow Portable Oxygen Concentrator
Pulse Flow Portable Oxygen Concentrator

Ask For Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-1061

By End User

Hospitals
Homecare
Ambulatory Surgical Centres
Travel Agents

By Region

North America
Latin America
Western Europe
Eastern Europe
APEJ
MEA
Japan

Top Related Reports Healthcare Market Insights

https://gezelligkletsen.nl/read-blog/11095

https://vishalht.look4blog.com/52970802/body-contouring-market-regional-outlook-trends-key-companies-profile-cagr-and-forecast-to-2032

https://ai.wiki/read-blog/26640

https://vishalht.ezblogz.com/44552976/body-contouring-market-key-opportunity-analysis-growth-trends-2032

https://jejaring.lokadaya.id/read-blog/2594

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Ophthalmic Lasers Market to Display Impressive Growth of 5.4% with Rising Demand by 2022-2030

The global ophthalmic lasers market is anticipated to grow from a market value of US$ 884.3 Mn in 2022 to US$ 1.3 Bn by 2030, expanding at a moderate CAGR of 5.4%.

Technological advancements have deeply penetrated every facet of the healthcare industry, and the ophthalmic lasers market growth is no exception. Over the years, ophthalmic disorders such as diabetic retinopathy, refractive errors, glaucoma, cataract and age related macular degeneration (AMD) have surged exponentially. This has accelerated demand for advanced surgical procedures.

The introduction of ophthalmic laser surgery has revolutionized ophthalmic care in unprecedented ways. Majority of these technologies are being deployed in cataract surgeries, attributed to the disorder’s widespread prevalence across all continents. Advancements such femtosecond laser surgeries have proven highly instrumental in streamlining ophthalmic procedures, offering lightning speed detection of faulty tissues.

Such reduced detection and treatment timeframes act as major growth catalysts for the global ophthalmic lasers market, which is anticipated to reach a value of US$ 1.3 Bn by 2030.

Consumers have long placed a high importance on keeping good eye health in order to preserve their vision. The market size for ophthalmic laser machines is expanding, providing attractive prospects for ophthalmic laser producers thanks to rising spending on keeping good eye health and rising awareness of various ophthalmic disorders.

Growing consumer desire for minimally invasive laser treatments and the quick expansion of the eye infection treatment market have a significant impact on ophthalmic laser sales.

Ophthalmic lasers are special treatments used to repair damaged corneas and treat disorders that might impair vision, including glaucoma, macular degeneration, and diabetic retinopathy. Due to their safe, precise, and accurate character, they have grown to be highly sought-after goods utilised in surgical treatment for a variety of eye problems.

Request Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1529

As diabetes incidence increases globally, there has been a noticeable increase in the number of prevalent ocular problems over the past few years, including cataract, glaucoma, and others. During the projected period, this is anticipated to offer a favourable environment for the leading producers of ophthalmic laser devices.

The market for ophthalmic laser devices is therefore growing as there is a growing preference for safe and efficient techniques like laser vision correction (LVC) to do away with the necessity for glasses or contact lenses.

During the evaluation period, it is also anticipated that the market for laser therapy equipment would thrive and that the popularity of minimally invasive surgeries will increase.

Ophthalmic laser sales made up around 41% of the US$ 2.0 Billion global market for laser therapy equipment in 2021, according to Future Market Insights (FMI).

Leading producers of ophthalmic lasers are anticipated to spend more on improved product designs and technological advancements in order to offer ophthalmologists cutting-edge products for use in routine ocular procedures. Due to this, demand for ophthalmic laser equipment will increase during the ensuing time.

Ophthalmic Lasers Market- Key Highlights

Ophthalmic lasers market shall expand steadily at a CAGR of 5.4% from 2022-2030
Cataract surgeries shall account for the majority share of the global ophthalmic lasers market
Femtosecond laser surgery to hold maximum sway throughout the forecast period
North America shall retain market hegemony, owing to increasing regulatory approvals for laser surgeries by authorities
Asia & Europe to contribute nearly identical revenue shares due to rise in surgeries amidst their geriatric population

“Vendors in the ophthalmic lasers landscape are striving to introduce novel product lines, equipped with multi-frequency selection modes to reduce exposure to intense laser bursts, preventing healthy tissue damage,” infers the FMI analyst.

Get In Touch With Our Team For 20% Flat Discount: https://www.futuremarketinsights.com/ask-question/rep-gb-1529

Competition Dashboard

Prominent vendors in the ophthalmic lasers market include are ZEISS International, Nidek Inc., Bausch & Lomb Inc., Abbot Laboratories Inc., SCHWIND Eye-Tech Solutions, Ziemer Ophthalmic Systems AG, Novartis AG (Alcon), LENSAR LLC., iVIS Technologies and NKT Photonics A/S. New product launches and collaborations have helped these players acquire firm footing.

In 2018, ZEISS International rolled out its VISUFIT 1000 digital 3D centration data determination and consultation platform, offering a three-dimensional facial reconstruction which enables ophthalmologists perform precise centration processes on patients.

In July 2022, SCHWIND Eye-Tech acquired CE approval for its SCHWIND ATOS femtosecond laser, permitting eye surgeons to incorporate the technology in their SmartSight refractive surgery procedures.

More Insights on the Ophthalmic Lasers Market

A recent market study published by FMI on the ophthalmic lasers market includes the global industry analysis of 2014-2021 & opportunity assessment for 2022-2030, and delivers a comprehensive assessment of the most important market dynamics. The report provides a balanced, unbiased analysis of the overall market scenario based on product type (excimer lasers and femtosecond lasers), application (refractive surgery, cataract surgery, capsulotomy, trabeculoplasty and diagnostics), end-user (hospitals, ophthalmology clinics and ambulatory surgical centers) and region (North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa).

Request for Customization: https://www.futuremarketinsights.com/customization-available/REP-GB-1529

Ophthalmic lasers market by Category

By Product:

Excimer Lasers
Femtosecond Laser

By Application:

Refractive Surgery
Cataract Surgery
Posterior Capsulotomy
Trabeculoplasty
Diagnostic

By End user:

Hospital
- 500 Bedded+
- 250-499 Bedded
- Less than 250
Ambulatory Surgical Centers
Ophthalmology Clinics

Top Related Reports Healthcare Market Insights

https://loop.joshwho.net/posts/27910200?utm_source=manual

https://www.xaphyr.com/blogs/158814/Body-Contouring-Market-Creating-Opportunity-Demands-Supply-Value-Chain-Process

https://app.goodnightjournal.com/journal/0d58c176-1eb4-433e-97b2-5ba8d11a8e9a

https://www.zedlike.com/blogs/18488/Body-Contouring-Market-Segmentation-Application-Technology-Analysis-Research-Report-To

https://social.noncense.org/read-blog/10840

About Future Market Insights (FMI)

Contact:

Pulmonology Devices Market– Global Industry Analysis and Deeper Insights | FMI

According to Future Market Insights (FMI), driven by the rising incidence of respiratory diseases the demand for pulmonology devices market will rise. Respiratory disorders such as asthma, chronic obstructive pulmonary disorder (COPD), and lung cancer is on the rise globally. Smoking and unhealthy living environment are often identified as common causes fuelling the incidence of respiratory disorders.

Government initiatives supported by public and private organizations to spread awareness has led people to focus on early diagnosis of medical conditions to avoid delay in treatment. Furthermore, a number of players are developing new products to expand their product portfolio as well as to maintain their position in the market.

For an instance Olympus has launched a few unique pulmonology devices such as the flexible bronchoscope that has helped the company in maintaining its position in the market. A large number of domestic players are slowly emerging in Asia Pacific. Rise in healthcare expenditure in developing countries and improving reimbursement policies are causing shift in focus among market players from developed to developing countries.

Moreover, the availability of pulmonology devices for healthcare professionals has been impacted by COVID-19 supply chain crisis. However, there are measures taken to manage this situation. Governments have relaxed controls to make supply easy. Export controls have been made easy by several manufacturing countries.

Major manufacturers in the pulmonology devices market are geared up and focusing on local production of pulmonology devices. According to the report, the increasing cases COPD and lung cancer will continue fuelling demand in the market.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-13036

Key Takeaways from pulmonology devices Marker Study

The demand for pulmonology devices is expected to get higher, enabling the market to exhibit 10.8% CAGR between 2020 and 2030
Backed by increasing healthcare spending, the U.S. is expected to account for nearly 90% sales in North America
Favorable reimbursement policies will enable the U.K. to exhibit 13% y-o-y growth in 2021
Germany and France will showcase increasing investment towards expanding healthcare infrastructure, in turn fuelling the demand for pulmonology devices
Within East Asia, Japan and South Korea will represent highly attractive markets for sale

Who is Winning?

Leading players in the pulmonology devices market on strengthening their market position though the Acquisition, Partnerships and expansion. For Instance,

In February 2019, the Conmed Corporation acquired privately-held Buffalo Filter LLC, a leader in surgical smoke evacuation technologies. The company’s comprehensive product portfolio includes smoke evacuation pencils, smoke evacuators, and laparoscopic solutions.
In November 2019, Cook Medical opened new facility in India. This office enables the company to expand its business in emerging markets.
In January 2019, the Verathon, Inc launched GlideScope® BFlex, a single-use flexible bronchoscope that offers optimal visibility and maneuverability for routine airway and bronchoscopy procedures.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-13036

Pulmonology devices Market by Category

Product

Pulmonary Biopsy Devices
- Single- Use Biopsy Forceps
- Cytology Brushes
- Microbiology Brushes
Endobronchial Ultrasound (EBUS) Needles
- Endobronchial Ultrasound Fine Biopsy Needles
- Endobronchial Ultrasound Transbronchial Aspiration Needles
Airway Stents
- Silicon Stents
- Nitinol Stents
- Stainless Steel Stents
Airway Extraction Baskets
Single-Use Bronchoscopes

Indication

Lung Cancer
COPD
Foreign Body Extraction
Tracheal and Bronchial Stenosis
Others

End User

Hospitals
Pulmonology Clinics
Ambulatory Surgical Centers

Region

North America
Latin America
Europe
East Asia
South Asia
Oceania
MEA

Table of Content

Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

3.3. Disease Epidemiology, By Region

3.4. Technology Assessment Vs. Application

3.5. Regulatory Scenario

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-13036

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Autoclaves Market Is Expected to reach USD 3.17 Bn by 2030

The global autoclaves market is estimated to be valued at US$ 2.09 Bn in 2022 and is expected to reach US$ 3.17 Bn by 2030, finds Future Market Insights (FMI) in a recent market survey. Gravity autoclave accounts for about 54.0% of the market value share of the product segment in 2021

According to the Centers for Disease Control and Prevention (CDC), on any given day, about 1 in 31 hospital patients has at least one health-care associated infection. Autoclaving destroys microorganisms with higher efficiency than dry heat. Hence autoclaves are registering increasing applications in the healthcare industry.
While the outbreak of novel coronavirus has taken a toll on the market affecting its growth, it is recovering steadily to bounce back. Patient admissions in hospitals and other healthcare facilities has increased, which is in turn fuelling the demand for autoclaves in the recent year.

FMI offers an in-depth analysis and overview of the global autoclaves market, covering factors enabling its growth, creating prospects, and key threats.
Some of the key takeaways from the report are highlighted below-

The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the global autoclaves market share.
Floor standing autoclaves will gain traction due to the high for laboratory applications
This study presents the analytical depiction of the global autoclaves market along with the current trends and future estimations to determine the imminent investment pockets.
The current market is quantitatively analyzed from 2021 to 2030 to highlight the global autoclaves market growth scenario. Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
The report provides a detailed global autoclaves market analysis based on competitive intensity and how the competition will take shape in coming years.

“The rising awareness among the hospital staff, doctors, and patients regarding the hospital acquired infections is spurring the growth of the autoclaves market. The outbreak of COVID-19 pandemic has resulted in unbridled rise in patient pool across hospitals and healthcare centers, increasing the risk of hospital acquired infections. According to the National Centre for Biotechnology Information (NCBI), the risks of Central Line-Associated Bloodstream Infection (CLABSI), Catheter Associated Urinary Tract Infection (CAUTI), and others are higher in COVID-affected patients. This has been fuelling the demand for autoclaves and the trend is expected persist over the next couple of years,” says an FMI analyst.

Request Sample Copy of Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12890

COVID-19 Impact Analysis
The outbreak of COVID-19 pandemic caused decline in the growth of market earlier this year. The sudden lockdown, coupled with restrictions imposed, had severely affected manufacturing units of the autoclaves. However, autoclaves being an integral part of the sterilization process started experiencing surge in demand soon after getting over the temporary period of lull. The ongoing pandemic has resulted in higher requirement for sterilized and clean environment across healthcare facilities, which is substantially pushing the demand curve for autoclaves upward.

As per Medical Product Outsourcing (MPO), autoclaves are staples in the healthcare industry and they are used extensively for high-pressure steam sterilization on various tools and industrial components, especially during COVID-19 pandemic.

According to the World Health Organization (WHO), biosafety levels BSL-2 and BSL-3 are required in order to handle COVID-19 by maintaining clean and safe environment. As laboratory autoclaves are ideal for sterilization of contaminated instruments, waste, laboratory equipment, and others while maintaining these standards, they are highly required in diverse end-user industries starting from pathology laboratories to academic and research institutes.

Key Market Players

Astell Scientific
Shinva
Steris Corporation
Getinge
Belimed
MELAG,
Panasonic Biomedical Tuttnauer.

Autoclaves Market by Category

By Product Type:

Gravity Autoclave
Vacuum-induced Autoclave

By Modality:

Floor standing
Bench Top
Wall Mounted
Portable

By Loading Type:

Top Loading
Front Loading
Pass-Through

By Chamber Type:

Cylindrical
Rectangular

By End-User:

Hospitals
Office-Based Clinics
Academic and Research Institutes
Research Laboratories
Pathology Laboratories
Biopharmaceutical Companies

Request Customization of the report:

https://www.futuremarketinsights.com/customization-available/rep-gb-12890

Table of Content
1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion and Exclusions

Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Type Innovation / Development Trends

Key Success Factors

4.1. Product Type Adoption Rate/Usage Analysis- Key Statistics

4.2. Key Promotional Strategies, By Key Manufacturers

4.3. Diseases Epidemiology By Region

4.4. New Product Launches

4.5. Products & Application Matrix

TOC Continue…

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-12890

About Future Market Insights, Inc.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Transradial Closure Devices Market Size to be worth USD 381.4 Mn by 2030

The transradial closure devices market is growing with the increasing cases of cardio vascular diseases all over the world. A new study by Future Market Insights (FMI) has projected the market to rise at 6.8% CAGR between 2022 and 2030. According to the report, demand will rise consistently on the back of surging cases of cardiovascular ailments caused by stress, unhealthy lifestyle, and others factors.

According to World Health Organization (WHO), every year cardiovascular diseases cause an estimated 31% of death occurring worldwide. Also a 2016 Heat Disease and Stroke Statistics update by the American Heart Association stated that over 15 million people in the U.S. have coronary heart disease.

With no signs of the incidence slowing down, the demand for procedures such as angiography, angioplasty, percutaneous coronary intervention (PCI), and others will continue rising. Consequently, the demand for transradial closure devices is surging rapidly all over the world.

Radial access is highly efficient in providing faster mobility to patients due to smaller incision. Furthermore, chances of infection at site is lower in radial access as compared to transfemoral access, which makes it highly preferred by diverse end users, starting from hospitals to specialized clinics.

The outbreak of COVID-19 pandemic is anticipated to impact the market negatively. The temporary period of lull could continue until the next year. However, the transradial closure devices market has high potential to grow further in the coming years.

FMI offers an exhaustive overview of the transradial closure devices market, its growth drivers, and restraints.

“Due to the rising cases of cardio vascular diseases, there has been increase in surgical and diagnostic procedures related to it. Transradial access (RA) being associated with less complications, is highly preferred by the various end users such as ambulatory surgical centers, hospitals, and others. In the coming years, the uptake of transradial closure devices will therefore rise especially since patients are increasingly willing to spend on procedures that ensure shorter hospital stays,” says an FMI analyst.

Some of the key takeaways from the report are highlighted below-

Band or strap based transradial closure type devices are expected to lead in the market during the forecast period
Disposable devices are anticipated to gain traction in terms of usage
Application of transradial devices in diagnostic segment will remain high throughout the forecast period
Among the end users, independent catheterization centres will emerge dominant in the coming years
North America will lead in the global market followed by Europe

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12841

COVID-19 Impact Analysis

Due to the outbreak of COVID-19 pandemic, manufacturing process of transradial closure devices was hampered during the lock down. Contrary to this, novel coronavirus might cause cardiovascular concerns, which has resulted in surge in demand for the transradial closure devices in hospitals, specialized clinics, and other segments.

As per the latest study by FMI, the global transradial closure devices market has high potential to overcome the threats posed by the ongoing pandemic and grow further in the coming years.

Who is Winning

The global transradial closure devices market is highly competitive. In order to strengthen their foothold market players are focusing on the launch of ultra-modern transradial closure devices.

For instance, Comed B.V has launched their new Io Radial Compression Tourniquet (IoRACT) which is effective to compress the radial artery puncture, post procedure in the current year. Their IoRACT is small, and especially designed to optimize compression, view the puncture side and deflate the compression balloon.

Merit Medical, Inc. has launched their exclusive PreludeSYNC Radial Compression Device which assists in achieving vascular hemostasis in the recent year. Their PreludeSYNC Radial Compression Device is available with the safety and convenience of a specialized connection device and syringe.

More Valuable Insights on Transradial Closure Devices Market

In the latest report by Future Market Insights, we offer an unbiased analysis of the global transradial closure devices market, providing historical data for the period of 2015-2019 and forecast statistics for the period of 2020-2030. In order to understand the global market potential, its growth and scopes, the market is segmented on the basis of product type (band/strap based, knob based, plate based), usage (disposable device, reusable device), application (surgical intervention, diagnostics), end user (hospitals, independent catheterization centers, ambulatory surgical centers, specialized clinics), across six major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, MEA).

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-12841

Key Segments Of Transradial Closure Devices Industry Survey

Transradial Closure Devices Market by Product:

Band/Strap-based Transradial Closure Devices
Knob-based Transradial Closure Devices
Plate-based Transradial Closure Devices

Transradial Closure Devices Market by Usage:

Disposable Transradial Closure Devices
Reusable Transradial Closure Devices

Transradial Closure Devices Market by Application:

Surgical Intervention
Diagnostics

Transradial Closure Devices Market by End User:

Hospitals
Independent Catheterization Centers
Ambulatory Surgical Centers
Specialized Clinics

Transradial Closure Devices Market by Region:

North America Transradial Closure Devices Market
Latin America Transradial Closure Devices Market
Europe Transradial Closure Devices Market
East Asia Transradial Closure Devices Market
South Asia & Pacific Transradial Closure Devices Market
Middle East & Africa (MEA) Transradial Closure Devices Market

Table of Content

Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

Key Success Factors

4.1. Transradial Closure Devices Adoption Rate/Usage Analysis- Key Statistics

4.2. Key Promotional Strategies, By Key Manufacturers

4.3. Key Regulations, By Region

Continued…!

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-12841

About Future Market Insights, Inc.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Cell Culture Media Bags Market worth USD 2.67 Bn by 2030 at a CAGR of 10.8%

In its new market study, Future Market Insights (FMI) estimates global cell culture media bags market will register impressive growth between 2020 and 2030, progressing at a stellar CAGR of 10.8%. Furthermore, the study projects that the market will surge past a global valuation of US$ 2.67 Bn by 2030. The report attributes the growth of the market to soaring demand for disposable packaging solutions in life sciences R&D activities and manufacturing of biopharmaceuticals.

Moreover, the emergence of innovative techniques such as four-layered films, which provide exceptional oxygen and moisture barrier properties, is also expected to boost demand.

Having analyzed the impact of the COVID-19 pandemic, the report opines that increasing health concerns and high emphasis on biopharmaceutical research will augur well for market growth during the assessment period.

COVID-19 Impact

The outbreak of COVID-19 is expected to positively influence the demand for cell culture media bags as players operating in the healthcare and pharmaceutical sectors emphasize on high quality and safe packaging and storing solutions. Moreover, an upsurge in the number of studies and researches during the pandemic to develop a vaccine is, in turn, propelling demand for cell culture media bags.

Likewise, the need for disposable and single-use solutions for applications such as large-scale purification, cell storage, protein purification, and polishing applications in the biopharmaceutical market will continue to offer remunerative opportunities to market players through the pandemic period.

List Of Key Players Covered in Cell Culture Media Bags Market are:

Parker Hannifin Corp
Pall Corporation
Sartorius AG
Thermo Fisher Scientific Inc.
GE Healthcare Inc.

Competitive Landscape:

In this fast-growing industry, partnerships and collaborations, product launches, expansions, and other strategies have been used to gain a major piece of the cell culture media bags market.

To meet the increased demand for bioprocess manufacturing activities, market participants are concentrating on up-scaling media bag production. In addition, producers are tackling problems and improved features of bags such as four-layered films that provide stronger oxygen and moisture barriers to the properties.

In this vein, Thermo Fisher Scientific released the CEDIA Mitragynine (Kratom) Assay, a novel immunoassay for kratom alkaloid mitragynine screening designed specifically for criminal justice and forensic purposes.Throughout the projection period, continuous product innovations will continue to define the competitive landscape of the market. Furthermore, industry participants are concentrating their efforts on producing products for specific end uses.

Get Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12670

Key Takeaways

2D bag designs are expected to account for over half of the market value, owing to their high flexibility
Very large bags (>3000 ml) will remain the most sought out size, owing to low contamination properties
By host cell, the bacterial cell segment is projected to account for the majority of market value, ascribed to an increasing number of studies on diseases caused by bacteria.
Biopharmaceutical manufacturing will remain a key end-use segment, capturing over 2/3rds of market value through the forecast period.
US will remain the largest market for cell culture media bags globally.

“Market players are investing in new product innovation and are focusing on procuring FDA approvals to facilitate wide-scale deployment,” remarks FMI analyst.

Who is Winning?

Cell culture media bags manufacturers are focusing on developing solutions that address the key challenges such as recycling of multilayer flexible packaging consisting of plastic and barrier materials. Moreover, new product development and strategic partnerships have been identified as key growth strategies adopted by market players.

In April 2019, Thermo Fisher Scientific launched a new immunoassay – CEDIA Mitragynine (Kratom) Assay – for kratom alkaloid mitragynine screening solely for criminal justice and forensic applications.
In August, 2015, Rim Bio partnered with Playmouth based Sentrol for sales and distribution of its single-use bio containers across the United States.

FMI’s report includes profiles of some of the most prominent names in the market including Parker Hannifin Corp, Pall Corporation, Sartorious AG, Thermo Fisher Scientific Inc., and GE Healthcare Inc.

Key Segments:

Cell Culture Media Bags Market by Bag Size:

Very Small Bags (< 150 ml)
Small Bags (151 – 500 ml)
Medium Sized Bags (501 – 1000 ml)
Large Bags (1001- 3000 ml)
Very Large Bags (>3000 ml)

Cell Culture Media Bags Market by Application:

Storage
Mixing
Processing
Gas Exchanges
Heat Transfer
Turbidity
Flow Rate Monitoring
Pressure
Viscosity

Cell Culture Media Bags Market by Host Cell:

Mesenchymal Cells
Plant Cells
Insect Cells
Bacteria Cells
Yeast Cells
Chinese Hamster Ovary
Baby Hamster Kidney

Cell Culture Media Bags Market by Bag Design:

2D Cell Culture Media Bags
3D Cell Culture Media Bags

Cell Culture Media Bags Market by End Use:

Life Science R&D
Biopharmaceutical Manufacturers

Cell Culture Media Bags Market by Region:

North America Cell Culture Media Bags Market
Latin America Cell Culture Media Bags Market
Europe Cell Culture Media Bags Market
East Asia Cell Culture Media Bags Market
South Asia & Pacific Cell Culture Media Bags Market
Middle East & Africa (MEA) Cell Culture Media Bags Market

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-12670

Detailed Table of Content:

Executive Summary
Global Market Outlook
Demand Side Trends
Supply Side Trends
Technology Roadmap
Analysis and Recommendations
Market Overview
Market Coverage / Taxonomy
Market Definition / Scope / Limitations
Inclusion and Exclusions
Key Market Trends
Key Trends Impacting the Market
Bag Size Innovation / Development Trends
Key Success Factors
Bag Size Adoption Rate/Usage Analysis- Key Statistics
Key Promotional Strategies, By Key Manufacturers
Pipeline Analysis
Diseases Epidemiology By Region
Key Regulations, By Region
Market Background
Macro-Economic Factors
Global GDP Growth Outlook
Global Healthcare Expenditure Outlook
Global Pharmaceutical Industry Outlook
Forecast Factors – Relevance & Impact
Growing Demand for Disposable Packaging Solutions
Increasing Prevalence of Chronic Diseases
Increased Shelf Life Offered by Single-Use Bags
Growing Applications in Primary Packaging
Increasing Production of Antibodies for Treatment of Disease
Rapid Progress in the Areas of Biopharmaceuticals, Oncology, and Stem Cell Research
Rising Number of Parenteral Bag Sizes in Pipeline
Value Chain
Market Dynamics
Drivers
Restraints
Opportunity Analysis

TOC Continued…!

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-12670

About Future Market Insights, Inc.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

PD-L1 Biomarker Testing Market will reach a value of USD 1.46 Bn by 2032 at a CAGR of 9.4%

The global PD-L1 biomarker testing market size was valued at US$ 541.6 Mn in 2021 and is expected to exhibit a CAGR of close to 9.4% over the forecast period (2022-2032).

Increasing incidence of cancer across the globe is underpinning the need for advanced cancer diagnosis equipment, which is expected to boost the market in the forthcoming years. Cancer immunotherapy is emerging as a new avenue for the development of biomarker testing, thereby augmenting the growth in the market.

Rising technological advancements in immunotherapy are propelling the adoption PD-L1 biomarker testing for non-small cell lung cancer as an effective means for therapeutic usage of PD-L1 proteins for benign lesions or tumor identification.

Moreover, the unmet needs of cancer treatments are addressed by the growing availability of high-quality immunotherapy products worldwide. Lifestyle changes, such as physical inactivity, tobacco consumption and smoking, as well as unhealthy diet are prime factors responsible for the growing burden of cancerous indications in the current scenario.

The emergence of cancer immunotherapy has advanced the diagnostic approach to cancer detection and management, thus propelling the growth in the PD-L1 biomarker testing market.

Key players operating in the market space are focusing on the development or extension of novel biologics using existing biologic resources for innovative product identification and provision of patented therapies.

Furthermore, the occurrence of adverse conditions such as organ failure and relapse into cancer through the process of chemotherapy is anticipated to fuel the adoption of PD-L1 biomarker testing among major healthcare facilities worldwide.

“Growing advancements in the field of oncology, along with accurate prediction insights offered by automated systems for biomarker testing will boost the sales of PD-L1 biomarker testing in the forthcoming years” says an FMI analyst.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-5897

Key Takeaways:

Based on product, PD-L1 22C3 assay kits segment is projected to account for over 53% of the market share by 2032, with sales increasing at a 10.2% CAGR over the forecast period.
In terms of indication, the NSCLS segment held 61.9% of the total market share in 2021, and the trend is expected to continue over the assessment period.
By end user, sales in the cancer research institutes segment accounted for 43.2% of the total market share in 2021.

North America is slated to be the largest leading region with a value share of over 61%, spearheaded by the U.S.

Sales in the U.K. will increase at a 10% CAGR over the assessment period.
China will emerge as a lucrative market, with demand growing at a 10.9% CAGR over the forecast period.

Competition Landscape

Leading players operating in the market are actively working in coherence with researchers to be able to acquire enhanced and innovative concepts to widen the therapeutic actions of the product. For instance:

In May 2020, F. Hoffman-La Roche AG acquired Stratos Genomics to develop DNA-based sequencing for diagnostic use.
In July 2020, Abcam plc. and Cancer Research UK partnered for the development and commercialization of novel antibodies to accelerate cancer research.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2032. The global PD-L1 biomarker testing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on PD-L1 biomarker testing market segment based on product (PD-L1 22C3 assay kit, PD-L1 28-8 assay kit, PD-L1 SP142 assay kit and PD-L1 263 assay kit), indication (NSCLS, melanoma, renal cell carcinoma, gastrointestinal tract malignancy, haematological malignancies, ovarian cancer and others), end user (hospitals, diagnostic laboratories and cancer research institutes) across seven major regions.

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-5897

Key Market Segments Covered In PD-L1 Biomarker Testing Industry Research

By Product:

PD-L1 22C3 Assay Kit
PD-L1 28-8 Assay Kit
PD-L1 SP142 Assay Kit
PD-L1 263 Assay Kit

By Indication:

NSCLS
Melanoma
Renal Cell Carcinoma
Gastrointestinal tract Malignancy
Haematological Malignancies
Ovarian Cancer
Other

By End User:

Hospitals
Diagnostic Laboratories
Cancer Research Institutes

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-5897

About Future Market Insights, Inc.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

PD1/PDL1 Inhibitors Market Size to Reach USD 98.5 Bn by 2030 | CAGR of 10.7%

PD-1/PD-L1 Inhibitors market Share is among the highest growing field in the pharmaceutical industry. PD-1/PD-L1 Inhibitors promise improved survival of patients, with low toxicity which is a huge market driving factor. The products available in the market for PD-1/PD-L1 inhibitors are increasingly meeting safety standards and are effective in the treatment of cancers. However, experts believe that the molecules in early clinical studies point towards safety concerns and high development cost can lead to high prices of the drug in the market which are a few challenged pharmaceutical companies have to encounter.

PD-1/PD-L1 Inhibitors Market: Region-wise Outlook

Based on geography, the PD-1/PD-L1 inhibitors market can be segmented into five major regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. At present, North America holds a leading position in the PD-1/PD-L1 inhibitors market followed by Europe. The major driving factors which have driven the growth of the PD-1/PD-L1 inhibitors market in these regions are constantly increasing the prevalence of various types of cancers, and demand for technologically advancements in the already successful approaches for treatment. The major companies are focusing on second generation therapies to improve the current treatment scenario with PD-1/PD-L1 inhibitors.
Following North America, European countries are also anticipated to show steady growth in the PD-1/PD-L1 inhibitors market. In the next few years, Asia-Pacific would show remarkable growth in the PD-1/PD-L1 inhibitors market as it is developing at a very rapid pace and has shown the emergence of many regional players. The factors which would fuel the growth of PD-1/PD-L1 inhibitors market in Asia-Pacific are increasing awareness regarding various types of cancers, increase the number of patients getting affected with the disease, and rapid development of the healthcare infrastructure across the Asian countries. PD-1/PD-L1 inhibitors market would evolve at a rapid rate across the regions. However, North America would maintain its position in the overall PD-1/PD-L1 inhibitors market.

PD-1/PD-L1 Inhibitors Market Overview

Immunotherapy treatment methods are evolving and are one of the prime methods for the treatment of cancer. PD-1/PD-L1 inhibitors have a targeted approach and decrease toxicity and hence resulting in increased efficacy. PD-1/PD-L1 inhibitors market is achieving advancements owing to the efficiency of the treatments.

PD-1/PD-L1 Inhibitors have been useful in the treatment of several cancers. PD-1/PD-L1 Inhibitors are being studies for the treatment of various type of cancers.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12644

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

The regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
The Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

PD-1/PD-L1 Inhibitors Market: Key Players

It is expected that with due course of time, there will be an entry of multiple pharmaceutical players in the PD-1/PD-L1 inhibitors market as PD-1/PD-L1 inhibitors have witnessed good investments from various key pharmaceutical companies. PD-1/PD-L1 inhibitors market currently has multiple ongoing deals and active research with many pharmaceutical companies looking to launch there products. Some of the top players operating in the PD-1/PD-L1 Inhibitors Market are Bristol-Myers Squibb, Merck & Co., F. Hoffmann-La Roche AG, Sanofi, Amgen, Gilead Sciences, AstraZeneca, Novartis, Pfizer, Celgene and many others.PD-1/PD-L1 Inhibitors Market has the presence of many regional players which have a huge market share in emerging countries.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-12644

Key Segments:

By Product:

Nivolumab
Pembrolizumab
Atezolizumab
Avelumab
Durvalumab

By Indication:

Melanoma
Non-Small Cell Lung Cancer (NSCLC)
Renal Cell Carcinoma (RCC)
Head and Neck Squamous Cell Cancer (HNSCC)
Bladder Cancer
Merkel Cell Carcinoma (MCC)
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle-East & Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-12644

About Future Market Insights, Inc.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Foley Catheter Market Insights By Type, Industry, Application & End-User | FMI

Foley catheters Market Size also known as urinary catheters, are flexible tubes that are passed through the urethra and bladder to facilitate easy drainage of urine. They are considered essential in the urology sector, aiding patients with bladder dysfunctions to drain urine into urine bags, and reducing urology-related complications. The prevalence of urological diseases – such as urinary retention, benign prostate hyperplasia (BPH), bladder obstruction, urinary incontinence, and prostate cancer – has witnessed a significant uptick in the recent past. According to the statistics of the Centers for Disease Control and Prevention (CDC), nearly 15-25% of hospitalized patients receive a urinary catheter annually. As the number of hospital admissions continues to rise year-on-year, there is a persistent need for foley catheters in hospitals, which are projected to remain a crucial end-use segment.

Likewise, the growing burden of urinary retention, a chronic condition in which individuals cannot voluntarily urinate, is propelling demand for foley catheters to facilitate easy drainage of urine. As per the estimates of the American Academy of Family Physicians (AAFP), approximately 4.5 to 6.8 per 1,000 men in the US suffer from urinary retention. As the incidence of disorders continues to grow across the world, the demand for foley catheters is poised to remain high for the years to come.

Along similar lines, the high prevalence of urinary incontinence, a condition that causes the urine to leak involuntarily, is projected to bestow remunerative opportunities to players in the foley catheters market. The severity of urinary incontinence rises with age, with men above 70 being the most affected. The expanding base of the geriatric population will continue to necessitate the usage of foley catheters.

COVID-19 Impact on Foley Catheters Market

COVID-19 is expected to create slight fluctuations in the growth trajectory of the foley catheters market. There has been a notable shift in priorities of healthcare institutions, with treatment for COVID-19 patients being the utmost priority across the world. Hospitals in severely affected nations such as the US and India have deprioritized non-essential hospitalizations, leading to a downfall in the demand for foley catheters. With urology not being the most concerning healthcare issue currently, the sales of numerous urology care devices, including foley catheters are likely to witness a decline across hospitals. However, the demand for foley catheters in long-term care facilities is poised to remain unhinged through the pandemic, and will continue to drive the sales of these devices.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-7769

Having analyzed and scrutinized all the aforementioned facets in its new market study, Future Market Insights (FMI) projects that the global foley catheters market will grow in value at a CAGR of nearly 5% between 2020 and 2030. Some of the key takeaways from the report include:

The global foley catheters market is expected to surge past valuation of US$ 2.2 Bn by the end of 2030.
By product type, 2-way foley catheters are poised to remain the most sought-out variants, owing to their wide availability and simple installation, and will hold more than half of the overall market value.
Among materials, latex-based foley catheters are expected to gain an edge over their counterpart, silicon-based foley catheters, backed by their ability to reduce urethral irritation.
Based on indication, urinary incontinence is expected to remain the largest segment, on the back of high incidence among geriatric population.
North America will remain at the forefront of the regional landscape ascribed to high expenditure on medical aids coupled with new product approvals.
Asia Pacific and Europe will continue to bestow remunerative opportunities to market players.

“With catheter-acquired infections being a major challenge to the adoption of foley catheters, manufacturers are focusing on developing products with materials and coatings that aid in reducing accumulation of bacteria, thus restraining the possibility of catheter-acquired infections among patients” remarks FMI analyst.

Who is Winning?

Major players in the market are focusing on developing advanced catheters that reduce the likelihood of the patient developing catheter-associated infections. To achieve the same, they are using novel materials and coatings, and are seeking approvals to commercialize their devices. On these lines,

C.R Bard is using silver-ion and antimicrobial coatings in the production of foley catheters to eliminate the risk of catheter-associated infections when used for long periods.
B. Braun Melsungen AG continues to develop its catheter product line named Actreen® catheters, designed specifically for urinary retention, and are coated with lubricants to make it comfortable and hygienic to use.
In 2019, Safe Medical Design Inc., procured FDA approval to commercialize its new catheter designed to reduce to urethral trauma.

FMI’s report includes profiles of some of the most prominent names in the market including Teleflex Incorporated, Cardinal Health, C.R Bard, B. Braun Melsungen AG, Coloplast A/S, Medtronic plc, Flume, ConvaTec Group, VOTG Medical, Sterimed Group, Ribbel International Limited, Angiplast Private Limited, Mais India Medical Devices Private Limited, and JK Medirise.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-7769

Key Segments

Type:

2 Way
3 Way
4 Way

Material:

Latex Foley Catheter

Hydrogel-Coated Latex Foley Catheters
Silicon-Coated Latex Foley Catheter
Silver-Coated Latex Foley Catheters
“PTFE (polytetrafluoroethylene) (teflon)
Coated Latex Foley Catheters

Silicon Foley Catheter

Hydrogel-Coated Silicone Foley Catheters
Pure Silicone Foley Catheters
Silver Coated Silicon Foley Catheters
Others

Indication:

Urinary Incontinence
Urethral Stricture
Chronic Obstruction
Neurogenic Bladder
Enlarged Prostate Gland/BPH
Prostate Cancer
Others

End-user:

Hospitals
Long Term Care Facilities
Others

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-7769

About Future Market Insights, Inc.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Fertility and Pregnancy Rapid Test Kits Market Size, Share & Forecast | USD 1.88 billion by 2030

Future Market Insights estimates that fertility and pregnancy rapid test kits market share will experience a spike in sales in 2022, reaching US$ ~ 1.3 Bn by the year end. The recently released report by award winning research firm, examine the data pertaining to increased cases of gynecological disorders such as uterine polyps, fibroids, polycystic ovarian disease, and unexplained infertility worldwide over past decade.

A three layered data of rapid pregnancy fertility test kits penetration across different channel and average monthly sales has been collected and global market statistics has been calibrated.

Consumer spending on self-diagnosis has increase by two fold in last three year, which is subjected to high associated and recurring cost for opting services from professional pathology labs. Raid test kits is convenient and comes with low complexity which captivate potential customers.

The report provides detail on other associated factors that has propelled the demand for these kits. One of such factor include the widespread availability of fertility and pregnancy rapid test kits on online sales channel as well its categorization as OTC product.

Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-607

Dual Capability Tests To boost The Sales of Fertility And Pregnancy Rapid Test Kits

Manufacturers are providing pregnancy test kits with dual capability and are also offering combined packs of fertility and pregnancy rapid tests, which can be used to qualitatively detect the presence of HCG hormone in both – urine and serum/blood. Users are rapidly adopting these combo kits as this eliminates the necessity to buy separate kits for urine and blood/serum testing. For instance, various products such as QuickVue HCG Combo, Test & Confirm, ICON 25 HCG, and many others are available commercially; which prove to be cost-effective. Covid-19 is adding to the sales of home-made combo kits; as social distancing forbids them from visiting the labs for tests.

Key Takeaways of Fertility and Pregnancy Rapid Test Market Study

Among distribution channels segmentation, pharmacies and drug stores are expected to hold nearly 50% of the market share
Rising age of first time pregnancy in North America is one of the major factors that drive its growth to the leading position in the market.

“Considering the rising adoption of fertility and pregnancy rapid testing kits, online sales platforms and OTC arms of the companies offer sizable opportunities for potential global market growth.” says the FMI analyst

Collaborations with e-Commerce Partners – A Key Strategy

The market for fertility and pregnancy test kits is rapidly growing and key players are looking for strategic options to expand globally. While most players have a fairly good distribution network locally as well as globally, the strong competition presses these players to look for options to reach out to more number of customers to sustain in the market.

Most companies focus on sales of fertility and pregnancy test kits through online sales channels. With products available online, buyers can choose from a wide variety of products to best suit their requirements. For instance many e-commerce portals such as Walmart, Amazon Inc., etc. offer variety of brands with discounted prices which attract the buyer.

Church & Dwight Co. Ltd., a major company in pregnancy and fertility test market generated 24% share of total revenue from sale of products through online distribution partner WalMart. PharmEasy is amongst the online pharmacy stores who delivers medicines to 98% PIN codes in India.

Request for Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-607

Want more insights?

Fertility and pregnancy rapid test market, a new study from Future Market Insights, opines on the fertility and pregnancy rapid test from 2012 – 2021 and presents demand projections from 2022 – 2030 on the basis of product (pregnancy rapid test (line-indicator devices (strips/dip sticks, mid-stream and cassettes) and digital devices and fertility rapid test (line-indicators and digital devices)), test type (LH urine, FSH urine, hCG blood, hCG urine), and distribution channel (pharmacies, drug stores, gynecology/fertility clinics, e-commerse and hypermarkets/supermarkets) across seven prominent regions.

Key Players :

Alere Inc.
Quidel Corporation
Prestige Brands Holdings, Inc.
Church & Dwight Co., Inc.
bioMérieux SA
Geratherm Medical AG
Abbott Laboratories
Procter & Gamble Co.
DCC Plc.
Swiss Precision Diagnostics GmbH

Fertility And Pregnancy Rapid Test Kits Market By Category By Product :

Pregnancy Rapid Tests
- Line-Indicator devices
  - Strips/Dip Sticks
  - Mid-Stream
  - Cassettes
- Digital
Fertility Rapid Tests
- Line-Indicator
- Digital